1,188 filings
Page 5 of 60
8-K
k10mv
31 Dec 19
Entry into a Material Definitive Agreement
7:36am
8-K
sb3hipk211 zjaf97cw
18 Dec 19
VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Adolescents with Obesity
7:35am
CT ORDER
qtyhp jqonqwxbrn9
13 Dec 19
Confidential treatment order
4:26pm
8-K
0rkvh trh9
20 Nov 19
Other Events
7:35am
4
j6vd2b t7dutot
18 Nov 19
VIVUS / Mark K Oki ownership change
4:51pm
4
qpu4u coom
18 Nov 19
VIVUS / Santosh T Varghese ownership change
4:51pm
CT ORDER
t7qlj 3m6j49
14 Nov 19
Confidential treatment order
1:28pm
8-K
tecs0m u5uh6lsbal4c5
8 Nov 19
VIVUS, Inc. Q3 2019 Earnings Conference Call
4:11pm
8-K
l8h9 3wa7nkk4
5 Nov 19
VIVUS Reports Third Quarter 2019 Financial Results
4:10pm
8-K
s39aw4kiefvkhe7qs6
28 Oct 19
VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
7:35am
8-K
ymdphufcw1k 3vip
21 Oct 19
VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit
7:35am
8-K
2x53ttp6wp6g3
7 Oct 19
VIVUS Announces Acceptance of Qsymia Decentralized Marketing Authorization Application in Europe
7:35am
8-K
n6a9 882ct8myk6u6g
3 Oct 19
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
7:36am
8-K
nz7t7
5 Sep 19
Regulation FD Disclosure
7:31am
8-K
0x2f2b4jggv7p4jwj2h
27 Aug 19
Other Events
7:36am
8-K
qjqkd75 kpuj2wb1x
20 Aug 19
Other Events
7:35am
8-K
ikh4biu1fv2v6t
9 Aug 19
VIVUS, Inc. Q2 2019 Earnings Conference Call
4:05pm
S-8
u57u6evbrfascq
6 Aug 19
Registration of securities for employees
4:52pm
8-K
s0pzljl7k3ot9
6 Aug 19
VIVUS Reports Second Quarter 2019 Financial Results
4:10pm